Skip to main content
Shahky Early Access Program Now Available—Sign-up to Learn More
Shahky Early Access Program Now Available—Sign-up to Learn More
 

Revolutionary Biofluid-Based Tests Using Exosomes to Advance Personalized Care

Our biofluid-based tests have the potential to deliver on the promise of personalized healthcare. These breakthrough tests are the industry’s first RNA-based liquid biopsies, which are designed to overcome the limitations of currently available tissue-based diagnostics and other liquid biopsies. Our tests leverage the power of exosomes, messengers that are released by all living cells and contain valuable biological information in the form of RNA, DNA and proteins. Our diagnostics are designed to aid clinicians in detecting, diagnosing and monitoring cancer as well as identifying the unique genetic composition of each patient’s disease with maximum sensitivity. With this information, physicians will be able to precisely match each patient to the best available treatment.